DOI: 10.4244/EIJV12I4A72

The Journal Citation Reports® Impact Factor: annual results 2016

As with the advent of every summer, the EuroIntervention Editorial Board looks forward to the annual announcement of our impact factor. This year’s announcement was particularly special as we have attained our highest impact factor to date, 3.8631.

Late last month, Thomson Reuters published the 2016 Journal Citation Reports® (JCR). Although far from being a perfect metric, the JCR is still the most influential measure of evaluating peer-reviewed journals2. The journal impact factor (JIF) ranking system is based on the number of times an average article is cited during the previous two years. Even though the impact factor was created in 1955 by Eugene Garfield3, the first JCR was only published in 1975. The 2016 results provide impact metrics from the 2015 data, which include 11,365 journals from 81 countries in 234 disciplines within the sciences and social sciences. Of these, 239 new journals have been included in the listing, having received their first JIF. When compared with their 2015 ratings, we can observe that 57% of journals have seen an increase in JIF, while 42% have seen a decrease. With a truly outstanding 131.723, CA: A Cancer Journal for Clinicians remains the journal with the highest JIF. Other notable results are The New England Journal of Medicine 59.558, The Lancet 44.002, Nature 38.138 and Science 34.661.

Unfortunately, 18 journals were excluded from this year’s ranking due to integrity concerns and will be re-evaluated after a year for reconsideration. The majority of exclusions were due to excessive rates of self-citation (>50%) which led to a distortion in the category ranking: the highest self-citer was the Journal of Physical Therapy Science (78%). Within our category, “Cardiac & Cardiovascular Systems”, the majority of the journals fall under the communally acceptable 20% self-citation level: EuroIntervention’s self-citation is on a par with JACC at 6% (Table 1).

Who cited who? Interestingly, in 2015, articles published in JACC CVI cited papers published in EuroIntervention in 2013 and 2014 108 times, followed by CCI citing our 2013/2014 papers 95 times. At the same time, in 2015, we cited JACC’s 2013/2014 papers 130 times, followed by our citing JACC CVI’s 2013/2014 papers 69 times. Finally, within our cardiovascular interventional subspeciality, the five-year trend remains relatively constant (Figure 1).

Figure 1. Five-year trend of major cardiovascular interventional journals. © 2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016).

We have discussed many times in these pages the merits and pitfalls of the impact factor. Concurrent to the impact factor ranking, we know downloads/website views/usage metrics are becoming increasingly important, particularly in terms of educational type papers. One may consider that usage metrics are more applicable to practitioners and that impact factors are more applicable to researchers. One aspect is certain –irrespective of the which metric is analysed (usage vs. citations)– at the dawning of the big data age, scientific analysis is becoming big business with Thomson Reuters currently valued at $3 billion4.

Volume 12 Number 4
Jul 20, 2016
Volume 12 Number 4
View full issue


Key metrics

On the same subject

10.4244/EIJV15I9A135 Oct 4, 2019
The EuroIntervention health check 2019
Mylotte D et al
free

10.4244/EIJV13I13A239 Jan 19, 2018
Beyond the impact factor: may we have your attention, please?
Capodanno D
free

10.4244/EIJV12I3A46 Jun 20, 2016
EuroIntervention at 100 issues
Serruys PW
free

10.4244/EIJ-E-21-00004 Jan 28, 2022
EuroIntervention: the 200th issue
Serruys PW
free

10.4244/EIJV14I13A241 Jan 18, 2019
Offering a new and more accessible vision of interventional medicine
Serruys PW
free

10.4244/EIJV14I1A1 May 20, 2018
Re-shuffling the Editorial Board
Serruys PW
free

10.4244/EIJV15I15A235 Feb 7, 2020
EuroIntervention: moving forward
Capodanno D
free
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved